Anakinra for rheumatoid arthritis
21 results
1 - 21
Anakinra for rheumatoid arthritis 
Anakinra for rheumatoid arthritis: Cochrane systematic review- Rheumatoid arthritis
- Biologics for rheumatoid arthritis
- Biologics for rheumatoid arthritis: an overview of Cochrane reviews
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Adverse effects of biologics: a network meta‐analysis and Cochrane overview
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
- Chronic diseases and pregnancy
- COVID-19 and other coronavirus infections